While tracers with higher brain penetration, volume of distribution (VT) values or binding potentials are desirable for temporally and spatially assessing Trk expression in conditions such as AD, the current tracers could certainly be beneficial in cases where Trk is overexpressed such as in numerous human cancers, both in the periphery and CNS. This evidence concerns the gene NTRK1 and cancer.